相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
Takaaki Masuda et al.
CANCER SCIENCE (2020)
Galectin-3 Is a Potential Mediator for Atherosclerosis
Ziyu Gao et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Galectin-3 is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes
Ana Lorenzo-Almoros et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Cardiac natriuretic peptides
Jens P. Goetze et al.
NATURE REVIEWS CARDIOLOGY (2020)
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The regulation and importance of monocyte chemoattractant protein-1
Vanessa Bianconi et al.
CURRENT OPINION IN HEMATOLOGY (2018)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inflammation and Immunity in Diseases of the Arterial Tree Players and Layers
Peter Libby et al.
CIRCULATION RESEARCH (2015)
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab
Ganesh Raghu et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Usefulness of a Combination of Monocyte Chemoattractant Protein-1, Galectin-3, and N-Terminal Probrain Natriuretic Peptide to Predict Cardiovascular Events in Patients With Coronary Artery Disease
Jose Tunon et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Stefan M. Nidorf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region
Jim Gilbert et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) A Retrospective Analysis
John J. V. McMurray et al.
CIRCULATION (2009)
Inflammation in Atherosclerosis From Pathophysiology to Practice
Peter Libby et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels
Lin Zhong et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes
James A. de Lemos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Chemokines and incident coronary heart disease -: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002
Christian Herder et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study
RC Hoogeveen et al.
ATHEROSCLEROSIS (2005)
C-reactive protein in atherosclerotic lesions - Its origin and pathophysiological significance
HJ Sun et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Calculating measures of biological interaction
T Andersson et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis
R Deo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes
JA de Lemos et al.
CIRCULATION (2003)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration
T Yamashita et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Monocyte chemoattractant protein-1 and coronary artery disease
U Ikeda et al.
CLINICAL CARDIOLOGY (2002)
Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion - Synergism with hypercholesterolemia
M Namiki et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Human C-reactive protein: expression, structure, and function
JE Volanakis
MOLECULAR IMMUNOLOGY (2001)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
